Literature DB >> 34546504

Adrenal pheochromocytoma: is it all or the tip of the iceberg?

Ke Wang1, Guanglei Tang1, Yang Peng1, Chang Li1, Wenhao Fu1, Ruixi Li1, Jian Guan2.   

Abstract

Adrenal pheochromocytoma is not always a simple retroperitoneal tumor but may be part of a more complicated condition. It often has a spectrum of complex and variable imaging features, may present as a collision tumor and composite tumor, and is associated with a variety of clinical syndromes. A comprehensive understanding of the clinical, pathological, and variable imaging manifestations of pheochromocytoma can help radiologists make an accurate diagnosis. This article reviews various special imaging features of pheochromocytoma and pheochromocytoma-related diseases.
© 2021. Japan Radiological Society.

Entities:  

Keywords:  Clinical syndrome; Computed tomography; Imaging features; Magnetic resonance imaging; Pheochromocytoma

Mesh:

Year:  2021        PMID: 34546504     DOI: 10.1007/s11604-021-01199-1

Source DB:  PubMed          Journal:  Jpn J Radiol        ISSN: 1867-1071            Impact factor:   2.374


  86 in total

Review 1.  Phaeochromocytoma.

Authors:  Jacques W M Lenders; Graeme Eisenhofer; Massimo Mannelli; Karel Pacak
Journal:  Lancet       Date:  2005 Aug 20-26       Impact factor: 79.321

2.  Pheochromocytoma and hypertension; an analysis of 207 cases.

Authors:  J B GRAHAM
Journal:  Int Abstr Surg       Date:  1951-02

Review 3.  Pheochromocytoma and functional paraganglioma syndrome: no longer the 10% tumor.

Authors:  Elisabeth Edström Elder; Grahame Elder; Catharina Larsson
Journal:  J Surg Oncol       Date:  2005-03-01       Impact factor: 3.454

Review 4.  Pathology and genetics of phaeochromocytoma and paraganglioma.

Authors:  John Turchini; Veronica K Y Cheung; Arthur S Tischler; Ronald R De Krijger; Anthony J Gill
Journal:  Histopathology       Date:  2018-01       Impact factor: 5.087

Review 5.  Update on Adrenal Tumours in 2017 World Health Organization (WHO) of Endocrine Tumours.

Authors:  Alfred King-Yin Lam
Journal:  Endocr Pathol       Date:  2017-09       Impact factor: 3.943

Review 6.  Pheochromocytoma.

Authors:  Frederick-Anthony Farrugia; Anestis Charalampopoulos
Journal:  Endocr Regul       Date:  2019-07-01

7.  The North American Neuroendocrine Tumor Society consensus guideline for the diagnosis and management of neuroendocrine tumors: pheochromocytoma, paraganglioma, and medullary thyroid cancer.

Authors:  Herbert Chen; Rebecca S Sippel; M Sue O'Dorisio; Aaron I Vinik; Ricardo V Lloyd; Karel Pacak
Journal:  Pancreas       Date:  2010-08       Impact factor: 3.327

Review 8.  European Society of Endocrinology Clinical Practice Guideline for long-term follow-up of patients operated on for a phaeochromocytoma or a paraganglioma.

Authors:  P F Plouin; L Amar; O M Dekkers; M Fassnacht; A P Gimenez-Roqueplo; J W M Lenders; C Lussey-Lepoutre; O Steichen
Journal:  Eur J Endocrinol       Date:  2016-05       Impact factor: 6.664

9.  Management of adrenal incidentalomas: European Society of Endocrinology Clinical Practice Guideline in collaboration with the European Network for the Study of Adrenal Tumors.

Authors:  Martin Fassnacht; Wiebke Arlt; Irina Bancos; Henning Dralle; John Newell-Price; Anju Sahdev; Antoine Tabarin; Massimo Terzolo; Stylianos Tsagarakis; Olaf M Dekkers
Journal:  Eur J Endocrinol       Date:  2016-08       Impact factor: 6.664

Review 10.  Personalized Management of Pheochromocytoma and Paraganglioma.

Authors:  Svenja Nölting; Nicole Bechmann; David Taieb; Felix Beuschlein; Martin Fassnacht; Matthias Kroiss; Graeme Eisenhofer; Ashley Grossman; Karel Pacak
Journal:  Endocr Rev       Date:  2022-03-09       Impact factor: 19.871

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.